Both improvement and worsening of adherence to antiretroviral treatment can be expected while transitioning HIV-positive adolescents to adult health care

Infect Dis (Lond). 2019 Jun;51(6):463-466. doi: 10.1080/23744235.2019.1582794. Epub 2019 Mar 11.

Authors

Justyna D Kowalska^{1

2}, Jolanta Popielska³, Agnieszka Wroblewska^{1

2}, Ewa Firląg-Burkacka¹, Andrzej Horban¹, Magdalena Marczyńska³

Affiliations

¹ a Department of Adults' Infectious Diseases , Medical University of Warsaw , Warsaw , Poland.
² b HIV Out-Patient Clinic , Hospital for Infectious Diseases in Warsaw , Warsaw , Poland.
³ c Department of Children's Infectious Diseases , Medical University of Warsaw , Warsaw , Poland.

PMID: 30856034
DOI: 10.1080/23744235.2019.1582794

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Anti-Retroviral Agents / therapeutic use*
Antiretroviral Therapy, Highly Active
Female
HIV / drug effects
HIV Infections / drug therapy*
HIV Seropositivity / drug therapy*
Humans
Male
Medication Adherence / statistics & numerical data*
Transition to Adult Care*
Young Adult

Substances

Anti-Retroviral Agents